CR9577A - Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil) - Google Patents
Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil)Info
- Publication number
- CR9577A CR9577A CR9577A CR9577A CR9577A CR 9577 A CR9577 A CR 9577A CR 9577 A CR9577 A CR 9577A CR 9577 A CR9577 A CR 9577A CR 9577 A CR9577 A CR 9577A
- Authority
- CR
- Costa Rica
- Prior art keywords
- chlorophenyl
- immediate release
- pharmaceutical formulations
- load
- high drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Abstract
Formulaciones farmaceuticas solidas de liberacion inmediata y con una carga de droga elevada que comprenden (4-clorofenil)[4-(piridilmetil)-ftalazin-1-ilo] micronizado, asi como sus sales aceptables para uso farmaceutico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05090167A EP1731154A1 (en) | 2005-06-07 | 2005-06-07 | Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)|4-(4-pyridylmethyl)pht halazin-1-yl| and salts thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CR9577A true CR9577A (es) | 2008-03-06 |
Family
ID=34938468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR9577A CR9577A (es) | 2005-06-07 | 2007-12-07 | Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil) |
Country Status (22)
Country | Link |
---|---|
EP (2) | EP1731154A1 (es) |
JP (1) | JP2008542421A (es) |
KR (1) | KR20080017443A (es) |
CN (1) | CN101242841A (es) |
AR (1) | AR054377A1 (es) |
AU (1) | AU2006256853A1 (es) |
BR (1) | BRPI0611818A2 (es) |
CA (1) | CA2610977A1 (es) |
CR (1) | CR9577A (es) |
CU (1) | CU20070272A7 (es) |
DO (1) | DOP2006000128A (es) |
EC (1) | ECSP078037A (es) |
GT (1) | GT200600243A (es) |
IL (1) | IL187906A0 (es) |
MX (1) | MX2007015495A (es) |
NO (1) | NO20080066L (es) |
PE (1) | PE20070012A1 (es) |
RU (1) | RU2007147953A (es) |
TW (1) | TW200716114A (es) |
UY (1) | UY29585A1 (es) |
WO (1) | WO2006131394A1 (es) |
ZA (1) | ZA200800113B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1958615A1 (en) * | 2007-02-13 | 2008-08-20 | Bayer Schering Pharma Aktiengesellschaft | Solid pharmaceutical formulations of a homogeneous dispersion of active principles having pH-dependent solubility |
EP1958616A1 (en) * | 2007-02-13 | 2008-08-20 | Bayer Schering Pharma Aktiengesellschaft | Pharmaceutical formulations of 1-[4-chloroanilino]-4-[4-pyridylmethyl] phthalazine or salts thereof |
TW201618783A (zh) | 2014-08-07 | 2016-06-01 | 艾森塔製藥公司 | 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO4950519A1 (es) | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
US6482802B1 (en) | 1998-05-11 | 2002-11-19 | Endowment For Research In Human Biology, Inc. | Use of neomycin for treating angiogenesis-related diseases |
-
2005
- 2005-06-07 EP EP05090167A patent/EP1731154A1/en not_active Withdrawn
-
2006
- 2006-06-06 TW TW095120061A patent/TW200716114A/zh unknown
- 2006-06-06 KR KR1020087000234A patent/KR20080017443A/ko not_active Application Discontinuation
- 2006-06-06 RU RU2007147953/15A patent/RU2007147953A/ru not_active Application Discontinuation
- 2006-06-06 BR BRPI0611818-6A patent/BRPI0611818A2/pt not_active IP Right Cessation
- 2006-06-06 MX MX2007015495A patent/MX2007015495A/es not_active Application Discontinuation
- 2006-06-06 WO PCT/EP2006/005601 patent/WO2006131394A1/en active Application Filing
- 2006-06-06 CN CNA2006800294846A patent/CN101242841A/zh active Pending
- 2006-06-06 AU AU2006256853A patent/AU2006256853A1/en not_active Abandoned
- 2006-06-06 PE PE2006000620A patent/PE20070012A1/es not_active Application Discontinuation
- 2006-06-06 CA CA002610977A patent/CA2610977A1/en not_active Abandoned
- 2006-06-06 CU CU20100122A patent/CU20070272A7/es unknown
- 2006-06-06 GT GT200600243A patent/GT200600243A/es unknown
- 2006-06-06 JP JP2008515152A patent/JP2008542421A/ja active Pending
- 2006-06-06 EP EP06762011A patent/EP1888073A1/en not_active Withdrawn
- 2006-06-07 DO DO2006000128A patent/DOP2006000128A/es unknown
- 2006-06-07 UY UY29585A patent/UY29585A1/es not_active Application Discontinuation
- 2006-06-07 AR ARP060102364A patent/AR054377A1/es unknown
-
2007
- 2007-12-05 IL IL187906A patent/IL187906A0/en unknown
- 2007-12-07 CR CR9577A patent/CR9577A/es not_active Application Discontinuation
- 2007-12-19 EC EC2007008037A patent/ECSP078037A/es unknown
-
2008
- 2008-01-04 ZA ZA200800113A patent/ZA200800113B/xx unknown
- 2008-01-04 NO NO20080066A patent/NO20080066L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR054377A1 (es) | 2007-06-20 |
WO2006131394A1 (en) | 2006-12-14 |
ECSP078037A (es) | 2008-01-23 |
BRPI0611818A2 (pt) | 2010-09-28 |
AU2006256853A1 (en) | 2006-12-14 |
GT200600243A (es) | 2007-07-16 |
IL187906A0 (en) | 2008-03-20 |
JP2008542421A (ja) | 2008-11-27 |
CU20070272A7 (es) | 2010-09-30 |
PE20070012A1 (es) | 2007-02-07 |
CA2610977A1 (en) | 2006-12-14 |
UY29585A1 (es) | 2007-01-31 |
NO20080066L (no) | 2008-03-06 |
RU2007147953A (ru) | 2009-07-20 |
ZA200800113B (en) | 2009-07-29 |
MX2007015495A (es) | 2008-02-22 |
EP1888073A1 (en) | 2008-02-20 |
TW200716114A (en) | 2007-05-01 |
EP1731154A1 (en) | 2006-12-13 |
DOP2006000128A (es) | 2006-12-15 |
KR20080017443A (ko) | 2008-02-26 |
CN101242841A (zh) | 2008-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR10160A (es) | Arildihidroisoquinolinas sustituidas con azaciclilo, procedimiento para su preparacion y su uso como medicamentos | |
CR20110110A (es) | Composicion farmaceutica | |
CL2008002051A1 (es) | Compuestos derivados de isoxazol-4-metoxi, triazol-4-metoxi o pirazol-4-metoxi, con actividad agonista del receptor x de farnesoide (fxr); composicion farmaceutica que los contiene; y el uso de los compuestos en la preparacion de medicamentos utiles para el tratamiento de dislipidemia y enfermedades relacionadas. | |
UY29701A1 (es) | Formulaciones líquidas para la administración controlada de derivados de bencisoxazol | |
NO20080220L (no) | Formuleringer med hoy medikament belastning og doseringsformer | |
UY30163A1 (es) | Nuevas ariltienopirimidinonas sustituidas con azaciclilo, procedimiento para su preparación y su uso como medicamentos | |
ECSP077243A (es) | Formulación de pelet de liberación extendida que contiene pramipexol o una de sus sales farmacéuticamente aceptable, un método para su fabricación y su uso | |
UY32203A (es) | Amino pirimidinas y su uso en terapia | |
ECSP088296A (es) | Compuestos terapéuticos | |
UY33201A (es) | Compuestos de pirazol como antagonistas de crth2. | |
IL195269A0 (en) | Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic | |
UY30165A1 (es) | Nuevas arildihidroisoquinolinonas sustituidas con aminolcoholes, procedimiento para su preparación y su uso como medicamentos | |
UY30460A1 (es) | Compuestos terapéuticos | |
MXPA06011467A (es) | Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid). | |
FR2949062B1 (fr) | Nouvelles formulations pharmaceutiques contre le mesusage des medicaments | |
SV2009003366A (es) | Estabilizacion de vitamina b12 | |
UY31788A (es) | Formulación farmacéutica sólida con liberación retardada | |
AR082493A1 (es) | Formulaciones a base de nalbufina, y sus utilizaciones | |
AR058047A1 (es) | Administracion de inhibidores de dipeptidil peptidasa | |
ECSP13012832A (es) | Compuestos de pirazol como antagonistas de crth2 | |
CR9577A (es) | Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil) | |
UY29561A1 (es) | Derivados de quinazolina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
CR9563A (es) | Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micromizado, y sus sales | |
EA200702386A1 (ru) | Твердая фармацевтическая композиция для продолжительного высвобождения 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения | |
CU20070271A7 (es) | Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil) [4-4-piridilmetil) ftalazin-1-ilo] no micronizado y sus sales |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |